|
Aida Pharmaceuticals, Inc. - Comparative Business Analysis Snapshot
Business Description
Aida Pharmaceuticals, Inc.. The Group's principal activity is to develop, manufacture and distribute of antibiotics, cardiovascular and anti cancer drugs primarily in Mainland China. It has a total of nine production lines for the manufacturing of antibiotics, cardiovascular and anti-tumor drugs in various forms, including injectable powder, injectable liquid, capsules, tablets and ointments. The new products under developments by the Group include 5-Deoxy-Fluorordine, Apoptotic Factor, Adefovir Dipivoxil Tablets, Methylcanthatidinimid and SYO2.
Competitor Analysis
This analysis compares Aida Pharmaceuticals, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
